Enzo Biochem (FRA:EZB) Interest Expense : €-1.13 Mil (TTM As of Jan. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Enzo Biochem's interest expense for the three months ended in Jan. 2024 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jan. 2024 was €-1.13 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Enzo Biochem's Operating Income for the three months ended in Jan. 2024 was € -1.31 Mil. Enzo Biochem's Interest Expense for the three months ended in Jan. 2024 was € 0.00 Mil. GuruFocus does not calculate Enzo Biochem's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Enzo Biochem Interest Expense Historical Data

The historical data trend for Enzo Biochem's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Interest Expense Chart

Enzo Biochem Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Interest Expense

Get a 7-Day Free Trial

-1.01

Enzo Biochem Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Interest Expense	Get a 7-Day Free Trial															-	-0.03	-1.10	-	-

Enzo Biochem Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.13 Mil.

Enzo Biochem (FRA:EZB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Enzo Biochem's Interest Expense for the three months ended in Jan. 2024 was €0.00 Mil. Its Operating Income for the three months ended in Jan. 2024 was €-1.31 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jan. 2024 was €2.77 Mil.

Enzo Biochem's Interest Coverage for the quarter that ended in Jan. 2024 is calculated as

GuruFocus does not calculate Enzo Biochem's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Enzo Biochem (FRA:EZB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (FRA:EZB) » Definitions » Interest Expense

Comparable Companies

NOTV VNRX BIOQ STIM PSNL PRE OCX MDXH TTOO XGN TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

ENZ:USA

Address

527 Madison Avenue, New York, NY, USA, 10022

Website

https://www.enzo.com

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.

Enzo Biochem (FRA:EZB) Headlines

No Headlines